FDA lists drugs with potential safety issues

FDA lists drugs with potential safety issues


A list of drugs currently being evaluated for potential safety issues by the US Food and Drug Administration (FDA) has been posted on its website. The list has been published under laws brought in last September that require the FDA to inform the public of new safety information or potential signals of serious risk.


Information is to be published each quarter detailing drugs that have been identified as having potential safety issues based on reports in the FDA’s Adverse Event Reporting System (AERS).

The list is intended to inform patients of potential safety issues and the agency has been keen to stress that there is no definite or casual relationship between the listed drugs and their risks. 

The list is part of the FDA’s goal of improving communication with patients but could cause more harm than good if incorrectly interpreted.

Comments

Popular posts from this blog

 Role of Blockchain in Healthcare Data Management

Demystifying AI in Drug Discovery: Transforming Pharma R&D

GREEN INITIATIVES IN INDIA : Sustainable Practices in Pharmaceuticals